Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check2 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added to the page history. This replaces the previous 'Revision: v3.5.3' in the history and signals an update to the record's revision metadata.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s software/version footer was updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check30 days agoChange DetectedThe study history shows a new revision label, v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.0 was added to the record history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page footer revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.4.2 added to the history; prior notices about funding and operating status (v3.4.1) remain in earlier versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.